Publication date: November 2026 Source: Clinical Lung Cancer, Volume 27, Issue 9 Author(s): Sreoshy Saha, Jongyeob Kim, Inae Park, Nitika Paudel, Jay C. Zeck, Peter J. Bergquist, Rebecca Krochmal, Chul Kim
Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review. // Clinical Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S1525730426001233?dgcid=rss_sd_all
Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review. Clinical Lung Cancer. https://www.sciencedirect.com/science/article/pii/S1525730426001233?dgcid=rss_sd_all
“Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review.” Clinical Lung Cancer.
@article{article40889,
title = {Durable Response After Pembrolizumab for Recurrent Tracheal Squamous Cell Carcinoma: A Case Report and Focused Literature Review},
journal = {Clinical Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S1525730426001233?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment